Adagio Medical Holdings (ADGM) Raw Materials (2023 - 2026)

Adagio Medical Holdings (ADGM) has 4 years of Raw Materials data on file, last reported at $1.4 million in Q1 2026.

• For the quarter ending Q1 2026, Raw Materials fell 11.54% year-over-year to $1.4 million; the trailing twelve-month figure through Mar 2026 stood at $1.4 million (down 11.54% YoY), and the FY2025 full-year result was $1.4 million, down 15.45% from the prior year.
• Raw Materials slipped to $1.4 million in Q1 2026, from $1.4 million in the prior quarter.
• In the past five years, Raw Materials ranged from a high of $2.5 million in Q3 2024 to a low of $1.4 million in Q1 2026.
• A 4-year average of $1.7 million and a median of $1.6 million in 2025 frame the typical range for Raw Materials.
• Across the five-year window, Raw Materials slumped 45.15% in 2025 and fell 11.54% in 2026, its largest moves.
• Tracing ADGM's Raw Materials over 4 years: stood at $2.2 million in 2023, then dropped by 23.88% to $1.7 million in 2024, then dropped by 15.45% to $1.4 million in 2025, then retreated by 4.15% to $1.4 million in 2026.
• Business Quant data shows ADGM's Raw Materials at $1.4 million in Q1 2026, $1.4 million in Q4 2025, and $1.4 million in Q3 2025.